In pharmacokinetic studies n 3748 , approximately 6 of subjects were poor metabolizers of clarinex-d defined as a subject with an auc ratio of 3-hydroxydesloratadine to clarinex-d less than 0. Continuer la lecture →

5 to 20 mg day of clarinex in 4 double-blind, randomized, placebocontrolled clinical trials of 2 to 4 weeks duration conducted in the united states. Continuer la lecture →